Introduction {#s1}
============

The White-Kauffmann-Le Minor (WKL) scheme summarizes antigenic *formulae* of all known *Salmonella* serovars, on the basis of antigenic variability in the outer membrane lipopolysaccharides (O antigen), flagellar proteins (H1 and H2 antigens) and capsular polysaccharide (Vi antigen) ([@B1]). The most recent edition of the WKL scheme has identified over 2,500 serovars belonging to the five subspecies of *Salmonella enterica* ([@B1], [@B2]).

Traditional serotyping of *Salmonella* based on slide agglutination has been used for decades worldwide ([@B3]), and it is still considered the gold standard method for *Salmonella* serotyping. According to this phenotype-based approach, the surface antigens are detected by agglutination of bacterial cells using specific *Salmonella* antisera ([@B3]). Traditional serotyping is labor intensive, and it requires trained technicians to provide valuable data ([@B3]). Another limitation of this method, which leads to inconclusive results, is a possible loss of expression of antigens required for definitive serovar identification (for example rough strains) ([@B4]). For all these reasons, molecular methods for *Salmonella* serotyping have been developed ([@B3]). An example of molecular alternative methods for *Salmonella* serotyping is a multiplex bead-based suspension array developed to detect the most common serovars using Luminex technology ([@B5]). Moreover, the technological advancements of Whole Genome Sequencing (WGS) and the improved bioinformatic analyses are revolutionizing surveillance programs and WGS data could also be used to derive information about *Salmonella* characteristics, such as serotype antimicrobial resistance determinants, virulence genetic factors, plasmid types, and *in silico* Multi Locus Sequence Type (MLST) ([@B6]).

Different *Salmonella* serovars generally display different antigenic *formulae*, but there are also some exceptions. Historically, different names have been assigned to serovars showing the same antigenic *formula* but differing either by biochemical characteristics, pathogenicity, or habitats ([@B1]).

The antigenic *formula* 6,7:c:1,5 is shared by different serovar: Paratyphi C, Typhisuis, Choleraesuis ([@B1]). Furthermore, three biotyping subdivisions on the basis of H~2~S production and the utilization of mucate and dulcitol have been described within Choleraesuis serovar: Choleraesuis *sensu stricto*, Choleraesuis var. Kunzendorf, and Choleraesuis var. Decatur ([@B7]).

Serovar Paratyphi C is associated with enteric fever in humans; serovar Typhisuis is associated with chronic paratyphoid/caseous lymphadenitis in swine ([@B8]) and serovar Choleraesuis may cause serious outbreaks of salmonellosis and paratyphoid in pigs ([@B9]), with clinical outcomes, such as enterocolitis and septicemia ([@B10]), often resulting in fatal systemic disease ([@B11]). This serovar is currently highly prevalent in North America and Asia, but it is rare in Australia and the European Union (EU) ([@B12]).

An unexpected and sudden outbreak of severe epizootic salmonellosis due to *S*. Choleraesuis occurred in wild boars in Italy between 2012 and 2014; recovered isolates were typed for outbreak investigation purposes ([@B13]). A total of 30 isolates belonging to the outbreak were serotyped using the slide agglutination method, and biochemical tests were performed to identify the biotype. Where serotyping didn\'t work, additional tests were used to determine the serotype.

Results suggest the benefit of a combination of *in silico* MLST and antigenic *formula* detection to deep insight into a specific case of uncertainty in *Salmonella* serovar attribution.

Materials and Methods {#s2}
=====================

Bacterial Isolates
------------------

A panel of thirty *Salmonella* wild boar isolates was included in this study ([Table 1](#T1){ref-type="table"}). All the isolates were collected by the Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy between 2012 and 2014. Isolation was performed according to ISO 6579:2002/Amd 1: 2007.

###### 

Entire panel of analyzed isolates and serotyping results using different approaches: phenotypic serotyping and biochemical tests, xMAP^®^ *Salmonella* Serotyping Assay (SSA), WGS (data analysis with SeqSero tool) and WGS (data analysis with *Salmonella* TypeFinder tool).

  **ID**      **Origin**   **Isolation year**   **Phenotypic serotyping/biochemical tests**            **xMAP SSA**   **WGS (Seq Sero)**   **WGS (*Salmonella* TypeFinder)**
  ----------- ------------ -------------------- ------------------------------------------------------ -------------- -------------------- -----------------------------------
  12/54912    WB           2012                 *S*. enterica subsp. enterica (Gr. C1 - 6,7: -: 1,5)   C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/100302   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/164369   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/118163   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/95668    WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/167530   WB           2012                 *S*. enterica subsp. enterica (-: -: 1,5)              -:c:1,5        -:c:1,5              *S*.Choleraesuis var. Kunzendorf
  12/150332   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/171410   WB           2012                 *S*. enterica subsp. enterica (-: c: 1,5)              -:c:1,5        -:c:1,5              *S*.Choleraesuis var. Kunzendorf
  12/87099    WB           2012                 *S*. enterica subsp. enterica (Gr. C1 - 6,7: -: 1,5)   C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/90074    WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/90639    WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/164644   WB           2012                 *S*. enterica subsp. enterica (-: -: 1,5)              -:c:1,5        -:c:1,5              *S*.Choleraesuis var. Kunzendorf
  12/78468    WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/163644   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/127550   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/90090    WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  12/159467   WB           2012                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  13/821      WB           2013                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  13/76379    WB           2013                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  13/9861     WB           2013                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  13/104977   WB           2013                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  13/66045    WB           2013                 *S*. enterica subsp. enterica (-: -: 1,5)              -:c:1,5        -:c:1,5              *S*.Choleraesuis var. Kunzendorf
  14/9953     WB           2014                 *S*. enterica subsp. enterica (-: -: 1,5)              -:c:1,5        -:c:1,5              *S*.Choleraesuis var. Kunzendorf
  14/28309    WB           2014                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  14/70644    WB           2014                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  14/82778    WB           2014                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  14/82812    WB           2014                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  14/98709    WB           2014                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  14/147295   WB           2014                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf
  15/37298    WB           2015                 *S*. Choleraesuis var. Kunzendorf                      C1:c:1,5       6,7:c:1,5            *S*.Choleraesuis var. Kunzendorf

*Information about origin (WB = wild boar) and year of isolation are reported*.

Phenotipic Serotyping and Biochemical Tests
-------------------------------------------

All *Salmonella* isolates were serotyped by slide agglutination with *Salmonella* antisera (Statens Serum Institut, Copenhagen, Denmark) and serovar names assigned according to the WKL; distinction between the biotypes of *S*. Choleraesuis was performed by biochemical tests (H~2~S production, mucate and dulcitol fermentation) ([@B1]).

xMAP^®^ *Salmonella* Serotyping Assay
-------------------------------------

*Salmonella* isolates were serotyped by xMAP^®^ *Salmonella* Serotyping Assay (SSA), Luminex Corp., Austin, TX, U.S. SSA is a molecular serotyping assay addressing a set of target genes involved in the expression of the most common *Salmonella* serotype-specific antigens ([@B4], [@B5]).

Whole Genome Sequencing and Data Analysis
-----------------------------------------

Genomic DNA was extracted using QIAamp DNA Mini Kit (Qiagen, Valencia, CA) and quantified with a Qubit 3.0 Fluorometer (Life Technologies, Carlsbad, CA). Libraries for sequencing were prepared using Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA). High-throughput sequencing was performed on Illumina MiSeq with 2 × 250 paired-end reads. Raw sequence data were submitted to the European Nucleotide Archive (<http://www.ebi.ac.uk/ena>) under accession number PRJEB27935.

Raw reads were assembled using SPAdes (version 3.9) ([@B14]), available online at the Center for Genomic Epidemiology (CGE) ([www.genomicepidemiology.org](http://www.genomicepidemiology.org)). The serotyping was performed analyzing contigs with SeqSero (version 1.2) ([@B15]) and raw reads with *Salmonella* TypeFinder version 1.4 (<https://cge.cbs.dtu.dk/services/SalmonellaTypeFinder/>) ([@B15]--[@B17]).

Results {#s3}
=======

Based on phenotypic serotyping and biochemical tests, 23 out of 30 isolates were shown to be *S*. Choleraesuis var. Kunzendorf by phenotypic serotyping and biochemical tests. All these isolates were assigned to the antigenic *formula* 6,7: c: 1,5 and showed the following biochemical features: dulcitol (--), H~2~S (+) and mucate (--).

Seven additional isolates displayed incomplete antigenic *formula*, in particular, two isolates did not present the first flagellar antigen (c), one isolate did not display the somatic antigen (Serogroup C1--antigens 6,7) and four isolates presented neither somatic nor the first flagellar antigens. The second flagellar antigen (1,5) was always detected ([Table 1](#T1){ref-type="table"}). The isolates with incomplete antigenic *formula* couldn\'t be definitively typed as *S*. Choleraesuis according to the traditional serotyping and were thus classified as *S. enterica subsp. enterica*.

*Salmonella* isolates were serotyped by xMAP^®^ SSA. Two out of the seven isolates harbored the entire panel of genes, which allowed to infer the complete antigenic *formula* (C1:c:1,5). Biochemical tests allowed the typing of these isolates as *S*. Choleraesuis var. Kunzendorf. The remaining five isolates did not display the genetic target of the relative somatic antigens.

On the basis of the WGS and data analysis with SeqSero tool, twenty-five isolates out of thirty presented a complete antigenic *formula* (6,7:c:1,5). The lack of somatic antigen sequence for the other five isolates was also confirmed by WGS analysis, leaving the typing incomplete.

Regarding the analysis with *Salmonella* TypeFinder tool, even though the antigenic *formulae* found with the preceding methods were confirmed for all tested isolates, it was possible to obtain only an indirect relationship for Sequence Type 145 with serovar Choleraesuis var. Kunzendorf.

All the results are reported in [Table 1](#T1){ref-type="table"}.

Discussion {#s4}
==========

The wild boar epizootic mentioned in this work was caused by *S*. Choleraesuis var. Kunzendorf, which is considered the typical biotype of this serovar causing swine infections ([@B9]). The characterization of the *Salmonella* isolates responsible for wild boar\'s mortality provided us the opportunity to test different approaches to solve a specific ambiguous case study. The entire panel of isolates was serotyped with a phenotype-based approach at first, followed by biochemical tests. These analyses are labor intensive and quite long. Another limitation of traditional serotyping includes a possible loss of expression of one of the tested antigens ([@B3]). Seven isolates did not express one of the antigens required for serotyping, thus the result for the serovar assignment was incomplete (*Salmonella enterica* subsp. *enterica*). This would have misled the outbreak definition, as isolates from the same outbreak could have been assigned to different serovars.

Molecular serotyping methods offer a high-throughput alternative to traditional ones, which can strengthen the public health response capacity ([@B18]). In this study, the traditional serotyping was supported by three molecular approaches aiming at resolving the incomplete assignment of some isolates to a specific serovar. xMAP^®^ SSA was a faster approach than the traditional serotyping, however, alone, it was not sufficient to discriminate *S*. Choleraesuis var. Kunzendorf for the entire panel of tested isolates. The two *Salmonella* isolates, showing absence of c flagellar antigen according to the phenotypic method, resulted to be *S*. Choleraesuis var. Kunzendorf by using xMAP^®^ SSA. However, the lack of somatic antigen in the remaining five isolates was also confirmed by the xMAP^®^ SSA, indicating the absence of the relative genetic target (*rfb* gene) ([@B4]).

The reads obtained from the entire panel of isolates by WGS were analyzed with two different tools. SeqSero tool, which assigns the serovar according to the antigenic *formula*, confirmed the results obtained by means of the molecular method.

Finally, *Salmonella* TypeFinder tool, which predicts the serovar using MLST typing ([@B17]), identified both serovar and biotype of the entire panel of the analyzed isolates as *S*. Choleraesuis var. Kunzendorf.

This study demonstrated that the antigenic *formula* detection might be not conclusive to cluster together isolates belonging to the same outbreak. The combined use of MLST and antigenic *formula* allowed, therefore, allocation of the investigated isolates to the same outbreak, irrespective of the antigenic *formula*. This suggests the perspective of integration of different data, both molecular and epidemiological, to provide deep insight into outbreak characterization in the presence of typing ambiguity.
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